ჩვენი პროდუქტები
ყველა პროდუქტი
ალიმენტური ტრაქტი და მეტაბოლიზმი
სისტემური გამოყენების ინფექციის საწინააღმდეგო
ანტიპარაზიტული პროდუქტები
სისხლი და სისხლ-წარმომქმნელი ორგანოები
კარდიო-ვასკულური სისტემა
დერმატოლოგია
შარდ-სასქესო სისტემა
ძვალ-კუნთოვანი სისტემა
ნერვული სისტემა
სასუნთქი სისტემა
სამომავლოდ დაგეგმილი პროდუქტები
|
|
Musculo-Sceletal System
Artoxan (Injections / Capsules) (Tenoxicam)
CONTENT:
Capsules. Capsule contains tenoxicam 20 mg.
Vials. Vial contains active ingredient: tenoxicam 20 mg.
PHARMACOLOGICAL PROPERTIES:
PHARMACODYNAMICS. Artoxan is effective non-steroid anti-inflammatory drug (NSAID)
with intense anti-inflammatory, analgetic and less expressed antipyretic action.
Properties of the preparation are de-termined by inhibition of both
cyclooxigenase enzyme isoforms that leads to decrease in metabolism of the
arachidonic acid and blockade of prostaglandin synthesis.
The anti-inflammatory effect is determined by reduction of capillaries
permeability (limits exudation), stabilization of lysosomal membranes (prevents
the exit of lysosoms enzymes, causing tissue damage), suppression of synthesis
or inactivation of inflammation mediators (prostoglandins, histamine, bradykinin,
lymphokins, comlement factors). It reduces the quantity of free radicals in the
center of inflammation, supresses chemotaxis and phagocytosis. Inhibits the
proliferative phase of inflammation, reduces postinflammatory sclerosis of
tissues; renders chondroprotective action. The preparation reduces painful
sensitivity in the center of inflammation and has the effect on thalamic centers
of pain, possesses desensitizing action (at long application). At rheumatic
diseases weakens the pain in joints at rest and at movement, reduces morning
constraint and swelling of joints, improves functions and increases volume of
movements of joints. PHARMACOKINETICS. After oral intake of capsules of Artoxan
absorbtion is fast and complete. Pick concentration will develop in 2 hours.
Intake after the meal decreases absorbtion. Bioavailability close to 100%. Has a
long period of half-life 60-75 h. It easily passes through the histohematogenous
barriers, well penetrates to the synovial fluid.
The preparation is characterized by high bioavailability - close to 100 %.
THERAPEUTIC INDICATIONS:
Inflammatory-degenerative diseases of the musculoskeletal system, accompanied by
pain syndrome:
- rheumatoid arthritis, gout arthritis, ankylosing spondylitis (Bekhterev's
desease);
- infectious nonspecific polyarthritis;
- osteoarthrosis, osteochondrosis;
- tendinitis, bursitis, myositis, periarthritis;
- arthralgia, neuralgia, myalgia, ishalgia, lumbago;
- traumas, burns.
CONTRAINDICATIONS:
- Hypersensitivity to tenoxicam or nother NSAID;
- Erosive or ulcerative lesions of GIT;
- Gastroenteric bleedings.
SIDE EFFECTS:
From digestive system: pains and unpleasant feelings in stomach, nausea,
flatulence.From nervous system: dizziness, headache.
Allergic reactions: itch, urticaria, erythema, syndromes of Stevens-Johnson's
and Lyell's.
Laboratory parameters: increase of creatinine and urea concentration in plasma,
increase of "hepatic" transaminases activity.
DOSAGE AND ADMINISTRATION:
Intended for intramuscular or intravenous injection, oral intake.
Prescribed in the dose of 20 mg once a day, maintenance dose - 10 mg a day.
In very strong pain syndrome it is possible to increase the dose up to 40 mg
once a day.
At acute attacks of gout arthritis: 20 mg 2 times a day within the first 2-3
days, then 20 mg once a day within 5 days.
PACKAGING:
3 vials with lyophilized powder and 3 ampoules with solvent in contour tray.
1 contour tray in carton box with enclosed leaflet.
10 capsules in blister. One blister with leaflet in carton box.
|